|
Nov 7
|
Aurinia Presents Breadth of Data from AURORA Clinical Program Underscoring Value of LUPKYNISⓇ (voclosporin) for Patients with Lupus Nephritis at ACR 2023
|
|
Nov 7
|
Wall Street Analysts See a 59.35% Upside in Aurinia (AUPH): Can the Stock Really Move This High?
|
|
Nov 3
|
Are Medical Stocks Lagging Aurinia Pharmaceuticals (AUPH) This Year?
|
|
Nov 3
|
Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) Q3 2023 Earnings Call Transcript
|
|
Nov 2
|
Aurinia Presents Breadth of Data at ASN 2023 Demonstrating Clinical Importance of LUPKYNISⓇ for Managing Lupus Nephritis
|
|
Nov 2
|
Aurinia Pharmaceuticals Inc (AUPH) Reports 60% Increase in Q3 Net Product Revenue
|
|
Nov 2
|
Aurinia Pharmaceuticals (AUPH) Reports Q3 Loss, Tops Revenue Estimates
|
|
Nov 2
|
Aurinia Pharmaceuticals Reports Third Quarter and Nine Months 2023 Financial and Operational Results
|
|
Aug 25
|
Is Aurinia Pharmaceuticals (AUPH) Stock Outpacing Its Medical Peers This Year?
|
|
Aug 21
|
Aurinia Appoints Two New Board Directors with Deep Experience in BioPharma Leadership, Commercial Strategy, Mergers and Acquisitions and Advancing Therapeutic Pipelines
|
|
Jun 29
|
Aurinia Board of Directors Announces Exploration of Strategic Alternatives to Maximize Shareholder Value
|
|
May 26
|
Aurinia Files Form S-8 to Register Shares Underlying Previously Disclosed Inducement Awards for Newly Hired Employees
|
|
Apr 28
|
Glass Lewis Recommends Aurinia Shareholders Vote "FOR" ALL Company Director Nominees at 2023 Annual Meeting
|
|
Apr 26
|
3 Biotechs That Might Get Bought Out in 2023
|
|
Apr 25
|
Toni Braxton and Aurinia Want People with Lupus Nephritis to Get Uncomfortable to Protect their Kidneys
|
|
Apr 24
|
Is Aurinia Pharmaceuticals Up for Grabs? Shareholder Suggests a Quick Sale for a Bigger Payday
|
|
Apr 24
|
Aurinia Pharmaceuticals to Release First Quarter Financial and Operational Results on May 4, 2023
|